Cargando...
Deriving meaningful insights from clinical trial and postmarketing safety data: Perspectives from India
Today, drug safety data collection in India is both manual and electronic with reporting of potential overlapping and duplicate data, which is likely incomplete for further review and analysis. Furthermore, standardized data collection and timelines are not aligned with international standards. Comp...
Guardado en:
| Publicado en: | Perspect Clin Res |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5384402/ https://ncbi.nlm.nih.gov/pubmed/28447016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-3485.203046 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|